sb 203580 has been researched along with aloe emodin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (aloe emodin) | Trials (aloe emodin) | Recent Studies (post-2010) (aloe emodin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 294 | 0 | 166 |
| Protein | Taxonomy | sb 203580 (IC50) | aloe emodin (IC50) |
|---|---|---|---|
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 2.88 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SS; Chung, JG; Kang, SE; Ko, JL; Lin, HT; Lin, ML; Lu, YC; Tang, CH; Wang, SG | 1 |
1 other study(ies) available for sb 203580 and aloe emodin
| Article | Year |
|---|---|
Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.
Topics: Anthraquinones; CDC2 Protein Kinase; Cell Cycle; Cyclin B1; Down-Regulation; Humans; Imidazoles; Matrix Metalloproteinase 2; Nasopharyngeal Neoplasms; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction | 2010 |